To evaluate if there is any clinical difference in patients 3.5-12kg who undergo cardiac surgery with cardiopulmonary bypass that do and do not receive blood products as part of their procedure. The main hypothesis of the study is that the patients undergoing bloodless cardiac surgery will have decreased morbidity and mortality when compared to the cohort that did receive blood as well as a shorter ICU and hospital length of stay.
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Age of patients undergoing bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Weight of patients undergoing bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Gender of patients undergoing bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Demographics of bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Diagnosis of patients undergoing bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Surgery performed in bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Previous surgery prior to bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Blood received during bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Volume transfused during bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Number of patients with unplanned reoperation in bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Number of patients with unplanned cardiac catheterization in bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Number of patients with a neurologic complication in bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Number of patients with chylothorax in bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Number of patients with vocal cord injury in bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Number of patients with diaphragm paralysis in bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Number of patients with pacemaker implantation in bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Number of patients with postoperative pneumothorax in bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Number of patients with wound infection in bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Number of patients with bleeding requiring reoperation in bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Number of patients with pericardial effusion in bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days
Number of patients who died following bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Timeframe: 30 days